12 Biggest Mid-Day Losers For Monday - Adaptimmune Therapeutics (NASDAQ:ADAP), Atara Biotherapeutics (NASDAQ:ATRA)

SAExploration Holdings, Inc. SAEX shares dipped 45.7 percent to $17.90. SAExploration shares have dropped 92.92 percent over the past 52 weeks, while the S&P 500 index has gained 3.74 percent in the same period.
Check Cap Ltd CHEK shares tumbled 24.6 percent to $2.29 after the company reported a $5.9 million financing.
Ceragon Networks Ltd CRNT fell 12.7 percent to $2.00 following Q2 results. Ceragon Networks reported Q2 profit of $49,000 on revenue of $70 million
Epizyme Inc EPZM shares declined 12 percent to $9.09. Epizyme reported a narrower-than-expected quarterly loss, but sales missed analysts’ expectations.
Research Frontiers, Inc. REFR shares declined 11.8 percent to $2.84. On Thursday, Research Frontiers reported a Q2 loss of $0.10 per share.
Atara Biotherapeutics Inc ATRA shares dropped 10.8 percent to $22.19 following Q2 results. Atara Bio reported a Q2 loss of $0.66 per share.
Hyster-Yale Materials Handling Inc HY fell 10.2 percent to $59.00 as the company posted downbeat quarterly earnings.
Adaptimmune Therapeutics PLC – ADR ADAP shares declined 10 percent to $7.84 after the company reported weak Q2 results.
Digital Ally, Inc. DGLY fell 9.5 percent to $5.14. Digital Ally reported a Q2 adjusted loss of $0.45 per share on revenue of $4.4 million.
TG Therapeutics Inc TGTX declined 8.1 percent to $5.53 after the company reported a wider-than-expected Q2 loss.
Novo Nordisk A/S (ADR) NVO shares dropped 4.6 percent to $47.59. Bank of America downgraded Novo-Nordisk from Buy to Neutral.
Dean Foods Co DF shares dropped 3 percent to $18.27 after the company reported weaker-than-expected quarterly earnings.

Market News and Data brought to you by Benzinga APIs